Eric Michael Lander MD (He/Him)
Hematologic Oncology
Site Research Leader - Minnesota Oncology
Join to View Full Profile
910 E 26th StSte 200Minneapolis, MN 55404
Phone+1 612-884-6300
Fax+1 612-884-6363
Dr. Lander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eric Lander is an oncologist in Minneapolis, MN and is affiliated with multiple hospitals in the area. He is a physician at Minnesota Oncology and serves as the Site Research Leader. He received his medical degree from University of Arizona College of Medicine-Tucson and has been in practice 4 years. He completed residency in internal medicine and fellowship in hematology/oncology at Vanderbilt University Medical Center. He specializes in GI medical oncology. He has numerous publications in peer-reviewed journals and experience in clinical trial design and implementation.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2021 - 2024- Vanderbilt University Medical CenterResidency, Internal Medicine, 2018 - 2021
University of Arizona College of MedicineClass of 2018
Certifications & Licensure
MN State Medical License 2024 - 2026
TN State Medical License 2022 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response.Eric Michael Lander, Vasily N Aushev, Brandon M Huffman, Diana Hanna, Punashi Dutta
JCO Precision Oncology. 2024-12-01 - 5 citationsGastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.Matthew R Strickland, Eric M Lander, Michael K Gibson, David H Ilson, Jaffer A Ajani
Journal of the National Comprehensive Cancer Network. 2024-03-19 - Advancing early onset colorectal cancer research: research advocacy, health disparities, and scientific imperatives.Andrea J Dwyer, Aniruddha Rathod, Carli King, F E R Vuik, Phuong Gallagher
Frontiers in Oncology. 2024-01-01
Press Mentions
Natera Announces New Signatera™ MRD Data at 2023 AACR Annual MeetingApril 14th, 2023- New Signatera™ MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023January 19th, 2023
- New Signateratm MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023January 19th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
